Sono-Tek Corporation (NASDAQ: SOTK) Q2 2026 Earnings Call | 10/14/2025
AI Summary
Overview: Sono-Tek Corporation, a leader in ultrasonic coating systems, reported its Q2 and first half fiscal 2026 results, showcasing modest revenue growth, record first-half revenues, and strong net income growth. The company highlighted its diversification strategy, with significant momentum in the medical device sector offsetting slower clean energy demand. A robust backlog and strong balance sheet support a positive outlook for modest full-year revenue growth.
Key Financial Highlights:
- Q2 2026:
- Revenue: Slightly up to $5.16 million from $5.15 million in Q2 2025, marking the sixth consecutive quarter above $5 million.
- Gross Profit: Increased 3% to $2.6 million (50% margin vs. 49% last year), driven by a favorable product mix of high-ASP systems and lower warranty costs.
- Operating Expenses: Decreased to $2.17 million from $2.23 million, due to lower marketing, selling, and R&D expenses, partially offset by higher G&A costs.
- Net Income: Rose 27% to $424,000 ($0.03 per share) from $341,000 ($0.02 per share).
- First Half 2026:
- Revenue: Record $10.3 million, up slightly from $10.19 million in H1 2025.
- Gross Profit: Up 6% to $5.3 million (51% margin vs. 49%), driven by product mix and favorable warranty expenses.
- Operating Expenses: Slightly down to $4.35 million from $4.45 million.
- Net Income: Increased 36% to $917,000 ($0.06 per share) from $672,000 ($0.04 per share).
- Balance Sheet: Cash and marketable securities at $10.6 million, no debt, and CapEx of $113,000 for facility upgrades (full-year CapEx expected at $300,000).
Business and Operational Highlights:
- Core Technology: Sono-Tek’s ultrasonic coating systems provide precision thin-film coatings, reducing material waste and supporting environmental compliance. The shift to complex, high-ASP systems (often >$300,000, some >$1 million) has driven growth.
- Diversification Strategy: Strong growth in the medical device sector (e.g., balloon catheter coating systems) offset a decline in clean energy orders due to U.S. policy shifts. Notable orders include a $5 million and a $2.8 million medical device contract.
- Market Performance:
- Medical: Q2 sales surged 150% ($602,000) to $1 million; H1 up 44% ($553,000), driven by balloon coating systems in the U.S., Europe, and China.
- Clean Energy: Q2 sales down 3% ($65,000) to $2.43 million; H1 up 90% ($901,000), led by solar coating systems.
- Electronics: Q2 down 1% ($22,000); H1 down 21% ($646,000) due to timing of semiconductor orders.
- Industrial: Q2 down 68% ($517,000); H1 down 67% ($711,000), impacted by non-repeating FY2025 orders.
- Geographic Performance:
- U.S./Canada: Q2 sales down 22% ($775,000); H1 down 5% ($324,000) due to clean energy slowdown.
- Asia: Q2 sales up 153% ($562,000); H1 up 74% ($647,000), driven by medical and clean energy sales in China, Japan, and South Korea.
- EMEA: Q2 up 25% ($288,000); H1 flat ($60,000 decline).
- Latin America: Q2 down $74,000; H1 down $160,000 due to weaker fluxing sales.
- Backlog: Near-record $11.2 million, reflecting strong order activity, with large medical orders expected to ship primarily in FY2027.
- R&D Investment: $1.3 million in H1 2026 (vs. $1.4 million in H1 2025), supporting product expansion and high-ASP system development.
- Forward-Deployed Engineering (FDE): The FDE model, involving engineers working directly in customer production environments, enhances system adoption, shortens sales cycles, and drives high-ASP system sales (60-70% of shipments tied to lab testing/FDE).
Strategic and Market Insights:
- Medical Device Momentum: Strong demand for balloon catheter and stent coating systems, with Sono-Tek establishing itself as an industry standard. The company’s advanced platforms offer higher ASPs and improved margins compared to earlier stent systems.
- Clean Energy: Despite anticipated declines due to U.S. policy shifts, commercial demand from solar and carbon capture customers remains robust.
- Semiconductor Opportunity: Recent success at a trade show (SemiCon) highlighted expanded product offerings, increasing interest in 300mm fab-directed systems, signaling future growth potential.
- China Market: Despite competition from lower-cost local vendors, Sono-Tek secured medical device orders in China due to superior quality, even at premium prices amidst tariffs.
- Trade/Tariff Resilience: Over 50% of sales are U.S.-based, and key components are manufactured domestically, minimizing tariff exposure.
Outlook:
- Full-Year FY2026: Updated guidance reflects modest revenue growth, balancing caution around clean energy policy shifts with optimism for medical device demand. The company expects continued margin expansion as high-ASP systems scale.
- Long-Term: Sono-Tek is confident in sustained growth, driven by its shift to complex, customized systems, proprietary technology, and diversified market exposure (medical, clean energy, semiconductors). Margin benefits from FDE and high-ASP systems are expected to materialize over the next 1-2 years.
About this video
Sono-Tek Corporation reported Q2 2026 net sales of $5.16 million, flat year-over-year and marking the sixth consecutive quarter above $5 million. Gross profit grew 3% to $2.6 million, and gross margin improved to 50% from 49% due to a favorable product mix and reduced costs. Net income rose 24% to $424,000 ($0.03 per share), driven by improved gross profit and lower operating expenses. Operating income surged 47% to $421,000, reflecting cost control and margin expansion. For the first half, sales reached a record $10.3 million, with net income up 35% to $909,000 and gross margin at 51%. Medical market sales jumped 150% year-over-year, led by balloon coating systems shipped to the U.S., Europe, and China. The backlog grew to $11.2 million, reflecting strong order momentum, and Sono-Tek closed the quarter with $10.6 million in cash and no debt, underscoring its solid financial position. The company expects modest full-year revenue growth, noting recent uncertainty around clean energy sector orders but continued strength and diversification in medical devices and high ASP systems. Operational highlights include ongoing product innovation, disciplined cost management, and expansion in core markets. Sono-Tek management reaffirmed its strategic focus on medical device solutions, anticipating continued demand growth and favorable long-term prospects despite short-term market variability. About Inside Ticker: Inside Ticker provides clear, timely, and professional coverage of earnings reports, market updates, and financial insights. Explore comprehensive analysis at https://www.insideticker.com/. HashTags: #sonotek #sotka #Q22026 #earnings #FinancialResults #Revenue #NetIncome #EPS #GrossProfit #GrossMargin #OperatingIncome #MedicalDevices #CoatingSystems #OrderBacklog #ProductInnovation #CostManagement #DebtFree #CashPosition #CleanEnergy #HighASPSystems #InvestorUpdate #InsideTicker #QuarterlyResults #StockMarket #BusinessStrategy #Manufacturing #Growth #MedicalMarket #diversification #MarginExpansion
Video Stats
More from this category

Dell Technologies Inc. (NYSE: DELL) Q1 2026 Earnings Call | AI Server Demand | 5/30/2025
Inside Ticker

Mama's Creations, Inc. (NASDAQ: MAMA) Q1 2026 Earnings Call | 6/3/2025
Inside Ticker

Sportsman’s Warehouse Holdings, Inc. (NASDAQ: SPWH) Q1 2025 Earnings Call | 6/3/2025
Inside Ticker

Hewlett Packard Enterprise Company (NYSE: HPE) Q2 2025 Earnings Call | 6/3/2025
Inside Ticker

Yext, Inc. (NYSE: YEXT) Q1 2026 Earnings Call | 6/3/2025
Inside Ticker

Elastic N.V. (NYSE: ESTC) Q4 2025 Earnings Call | Cloud Revenue Surges & AI Platform | 5/30/2025
Inside Ticker

CrowdStrike Holdings, Inc. (NASDAQ: CRWD) Q1 2026 Earnings Call | 6/3/2025
Inside Ticker

Zscaler (ZS) Q3 2025 Earnings Call | Revenue Beats & AI Security Highlights | May 2025
Inside Ticker

BARK, Inc. (NYSE: BARK) Q4 2025 Earnings Call | 6/4/2025
Inside Ticker

lululemon athletica inc. (NASDAQ: LULU) Q1 2025 Earnings Call | 6/5/2025
Inside Ticker

Sprinklr, Inc. (NYSE: CXM) Q1 2026 Earnings Call | 6/4/2025
Inside Ticker

Braze, Inc. (NASDAQ: BRZE) Q1 2026 Earnings Call | 6/5/2025
Inside Ticker
